Table 2.
Relationship between treatment, physical, and cardiac functioning:* NSABP B-36
| Treatment | Change from baseline to 12 months |
|
|---|---|---|
| Physical Functioning | LVEF | |
| Overall | −1.74 (−4.03, 0.55) | −2.61 (−3.39,−1.83) |
| AC | −0.46 (−3.64, 2.71) | −2.61 (−3.70, −1.53) |
| FEC-100 | −3.18 (−6.49, 0.14) | −2.65 (−3.79, −1.52) |
| Difference FEC-100 vs. AC | −2.72 (−7.33, 1.89) | −0.04 (−1.61, 1.53) |
| P value | 0.25 | 0.96 |
*
Changes are model-based and adjusted for age and corresponding baseline measure; evaluated at average age of 51.8 and average baseline PF-10 score of 79.4, or average baseline LVEF score of 64.8.